Up 64% in a month, here's why the Novonix (ASX:NVX) share price is supercharging right now

It's been a crazy month for Novonix shareholders…

| More on:
Businessman taking off in rocket-fuelled office chair

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Novonix Ltd (ASX: NVX) share price is roaring higher over the last month despite the company being relatively quiet.

Novonix's one and only price-sensitive release of the last 30 days dropped last week. It detailed the company's quarterly activities and cash flows.

On top of that, the Novonix share price had seemingly been riding a recent wave of enthusiasm for lithium. While Novonix doesn't deal directly with lithium, it works in the battery technology space.

Finally, news of Telsa Inc (NASDAQ: TSLA) may have piqued the market's interest in Novonix due to its leader's ties with the electric car manufacture. Last week, Tesla celebrated a significant milestone when its value surpassed US$1 trillion.

On Thursday, the Novonix share price closed at $8.54, 1.78% higher than its previous close and 64.5% higher than it was this time last month.

Let's take a closer look at what might be moving the graphite explorer and manufacturer's stock lately.

What could be fuelling the Novonix share price?

The only release the market has seen from Novonix over the last month was its activities and cash flow report for the September quarter. The Novonix share price rallied 8.5% on the day the company released its quarterly results.

Over the quarter just been, Novonix saw a loss of $6.9 million. It ended the period with around $290.9 million in cash and approximately $48.8 million of drawn finance.

That's enough to fund another 42.2 quarters if costs remain the same as the one just been.

Additionally, over the quarter just been, Novonix purchased a new battery anode production facility in the United States. It also saw Phillips 66 (NYSE: PSX) make a strategic investment in the company.

Excitingly, it also welcomed its new chief scientific advisor, Professor Jeff Dahn.

Dahn and his research group have an exclusive partnership with Tesla. For those who aren't aware, Dahn is the second connection Novonix has with Tesla.

The company's CEO, Dr Chris Burns, was previously Tesla's senior research engineer.

Finally, the Novonix share price's recent rally might be due to increased interest in battery technology companies and lithium producers.

Lithium stocks surged last week alongside the commodity's price. While Novonix doesn't deal in lithium itself, its stock tends to move alongside lithium shares, likely due to its involvement in the battery sector.

The continued upwards movement experienced by the Novonix share price could be a signal of the market's lasting excitement in the battery sector.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Tesla. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Winning woman smiles and holds big cup while losing woman looks unhappy with small cup
Share Gainers

Here are the top 10 ASX 200 shares today

It was a dour Tuesday for ASX investors.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why Brightstar Resources, Immutep, Pilbara Minerals, and Race Oncology shares are roaring higher

These shares are having a strong session on Tuesday. But why?

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Healthcare Shares

Guess which ASX 300 healthcare share is rocketing 28% on global expansion news

Investors are piling into the ASX 300 healthcare share on Tuesday. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a Garfield kind of Monday for investors.

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Share Gainers

Why Artrya, Clinuvel, Imugene, and Pilbara Minerals shares are storming higher today

These shares are starting the week in a positive fashion. But why?

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Share Gainers

4 ASX 200 stocks smashing the benchmark this week

Investors have been piling into these four ASX 200 stocks this week. Let’s see why.

Read more »